Erratum: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer Ann Oncol 2015; 26: 1923-1929 doi: 10.1093/annonc/mdv264

B. H. O'Neil, A. J. Scott, W. W. Ma, S. J. Cohen, D. L. Aisner, A. R. Menter, M. A. Tejani, J. K. Cho, J. Granfortuna, A. L. Coveler, O. O. Olowokure, J. C. Baranda, M. Cusnir, P. Phillip, J. Boles, R. Nazemzadeh, M. Rarick, D. J. Cohen, J. Radford, L. FehrenbacherR. Bajaj, V. Bathini, P. Fanta, J. Berlin, A. J. McRee, R. Maguire, F. Wilhelm, M. Maniar, A. Jimeno, C. L. Gomes, W. A. Messersmith

Research output: Contribution to journalComment/debate

15 Scopus citations
Original languageEnglish
Pages (from-to)1180
Number of pages1
JournalAnnals of Oncology
Issue number6
StatePublished - 18 Jun 2016

Cite this